CALIFORNIA | LOCAL
September 2, 1991 |
Diabetics who take human insulin produced by genetic engineering techniques are no more prone to dangerous side effects than if they take insulin derived from animals, a team of British physicians reported last week in the Lancet. The study is the first to test the two types of insulin on patients who specifically complained of problems when switched from animal to bioengineered drugs.
September 27, 1987
Would like to add a footnote to the excellent Bill Hughes "The Mature Traveler" article of Sept. 13. For traveling diabetics taking NPH U100 insulin, there is none to be had in Europe. I have tried in Greece, Austria and in the London Harrods pharmacy and five stores in the Boots chain. They have never heard of it, so take along enough to last your entire trip. HELEN RITER BOWLES Redlands
September 13, 2011 |
Inhaling a concentrated cloud of insulin through the nose twice a day appears to slow — and in some cases reverse — symptoms of memory loss in people with early signs of Alzheimer's disease, a new pilot study has found. The study involved only 104 people and is considered very preliminary. But it suggests that a safe, simple and cheap measure that boosts flagging metabolism in key areas of the brain could hold off or possibly derail the progression of the devastating neurological disorder in its early stages.
June 28, 2012 |
Diet researchers reported Tuesday that patients who had recently lost weight seemed to burn calories more efficiently in the crucial weight-maintenance phase when they ate a low-carbohydrate, Atkins-style diet than they did when they ate a traditional, higher-carblow-fat diet. The small but intensive study, which was published in the Journal of the American Medical Assn. , showed through various measurements of energy expenditure that patients burned about 300 more calories a day on a low-carb diet than they did on thelow-fat diet.
April 21, 2007 |
Argentine scientists said this week that they had created four cloned and genetically modified calves capable of producing human insulin in their milk, a step they said could cut the cost of treating diabetes. The newborn Jersey heifers will start producing the human hormone when they reach adulthood, said the biotechnology company behind the project, Bio Sidus.
March 8, 2008 |
Eli Lilly & Co. said Friday that it would terminate development of an inhaled insulin treatment for diabetes, which it was conducting in partnership with Alkermes Inc., after deciding that the product's potential for commercial success wasn't strong enough. Lilly's decision marks the third setback in recent months for inhaled insulin formulations, once deemed potential blockbuster products because of their greater convenience than standard injectable insulin. Cambridge, Mass.